MiniMed Group, Inc. Common Stock
MMED
Rang in Aktien
#3404
MiniMed Group, Inc. specializes in designing, producing, and distributing a... MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
Aktienkurs
$17.87
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$5.03B
Veränderung (1 Tag)
2.14%
Veränderung (1 Jahr)
-
Land
US
Handel MiniMed Group, Inc. Common Stock (MMED)
Kategorie
Healthcare
Dividendenrendite-Verlauf für MiniMed Group, Inc. Common Stock (MMED)
Dividendenrendite (TTM) von MiniMed Group, Inc. Common Stock (Aktienkürzel: MMED) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für MiniMed Group, Inc. Common Stock (MMED) von 2023 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
| Jahr | Dividendenrendite | ändert |
|---|---|---|
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | Dividendenrendite | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
IL
|
|
| 0.51% |
US
|
